Kimryn Rathmell on cancer workforce – National Cancer Institute
National Cancer Institute recently shared on LinkedIn:
“‘Capacity building today, to build our desired future, means ensuring that everyone working in cancer care is trained and empowered to deliver optimal care at the leading edge. It means that our workforce includes the best and brightest people who thrive on collaboration.’ – NCI Director, Dr. Kimryn Rathmell.
Learn more about the Virtual Clinical Trials Office, a pilot test to address staff shortages exacerbated by the pandemic.”
Source: National Cancer Institute/LinkedIn
Dr. Kimryn Rathmell is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers. Currently serving as the director of the National Cancer Institute, Dr. Rathmell continues to lead research initiatives and advance the understanding and treatment of kidney cancer, ultimately improving the lives of patients worldwide.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023